trial · primary record
Biospecimen Collection
Acral Lentiginous Melanoma
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 313 |
| Primary completion | 2026-10-30 |
| Primary endpoint | Two-Year Event-Free Survival Rate |
| Registry ID | NCT03698019 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:39.652Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03698019
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Biospecimen Collection · compound